Liver iron concentration in chronic viral hepatitis: A study of 98 patients

European Journal of Gastroenterology and Hepatology

Volumn 7, Issue 12, 1995, Pages 1203-1208

  Piperno, Alberto ^a   D'Alba, Roberta ^b   Fargion, Silvia ^b   Roffi, Luigi ^a   Sampietro, Maurizio ^b   Parma, Stefania ^a   Arosio, Valeria ^c   Fare, Maristella ^d   Fiorelli, Gemino ^b  

^a Policlinico di Monza   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d G Pini Orthopaedic Institute   (Italy)

Author keywords

Haemochromatosis; Hepatitis; HLA; Iron; Liver iron concentration

Indexed keywords

HLA A3 ANTIGEN; IRON;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHRONIC HEPATITIS; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HLA TYPING; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; IRON STORAGE; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING;

AGED; FEMALE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IRON; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPECTROPHOTOMETRY, ATOMIC;

EID: 0029611170     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-199512000-00014     Document Type: Article

References (24)

1. Deugnier Y, Battistelli D, Jouanolle H, Cuyader D, Cueguen M, Loreal O, ef al.:Hepatitis B virus infection markers in genetic hemochromatosis. A study of 272 patients, j Hepatol 1991, 13:286-290.
2. Piperno A, Fargion S, D’Alba R, Roffi L, Fracanzani AL, Vecchi L, et al:Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection.j Hepatol 1992, 16:364-368.
3. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al.:Hepatitis C virus and Porphyria cutanea tarda: evidence of a strong association. Hepatology 1992, 16:1322-1326.
4. Bacon BR, Fried MW, Di Bisceglie AM: A 39-year-old man with chronic hepatitis, elevated serum ferritin values, and a family history of hemochromatosis. Semin Liver Dis 1993, 13:101-105.
5. Jaffin BW, Ambinder EP: Hemochromatosis and hepatitis C. Hosp Pract 1991, 26 (suppl 3):50-51.
6. Nemser HS, Hammerman HS: Hemochromatosis, chondrocal-cinosis and hepatitis C. Hosp Pract 1991, 26 (suppl 31):51-52.
7. Lustbader ED, Hann H, Blumberg B: Serum ferritin as a predictor of host response to hepatitis B virus infection. Science1983, 220:423-425.
8. Felton C, Lustbader ED, Merten C, Blumberg BS: Serum iron levels and response to hepatitis B virus. Proc Natl Acad Sci USA 1979, 76:2438-2441.
9. Van Theil DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Cavaler JS: Response to a-interferon therapy is influenced by the iron content of the liver. j Hepatol 1994, 20:410-415.
10. Piperno A, D’Alba R, Roffi L, Fargion S, Mancia C, Fiorelli G: Relation between a-interferon therapy response and liver iron stores in chronic hepatitis C [abstract]. Hepatology 1993, 18:687.
11. Olynyk J, Reddy R, Dibisceglie AM, Jeffers LJ, Parker T, Radick, et al.:Hepatic iron concentration as a predictor of response to a-interferon therapy in chronic hepatitis C. Gastroenterology 1995, 108:1104-1109.
12. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measurement of iron status in patients with chronic hepatitis. Gastroenterology 1992, 102:2108-2113.
13. Scheuer PJ, Williams R, Muir AR: Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962, 84:53-64.
14. Barry M, Sherlock S: Measurement of liver iron concentration in needle biopsy specimens. Lancet 1971, i:100-103.
15. Summers KM, Halliday JW, Powell LW: Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990, 12:20-25.
16. Panajotopoulos N, Piperno A, Conte D, Mandelli C, Cesana M, Mercuriali F, et al.:HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives. Tissue Antigens 1989, 33:431-136.
17. Masachika S, Tsuyoshi N, Hideyo I: Statistical analysis of relationship between iron accumulation and hepatitis B surface antigens. Am I Clin Pathol 1985, 84:340-342.
18. Isomura T, Yano M, Hayashi H, Sakamoto N: Excess iron in the liver of patients with chronic hepatitis C. J Clin Electron Microsc 1992, 25:231-237.
19. Sorokin LM, Morgan EM, Yeon CC: Transformation-induced changes in transferrin and iron metabolism in myogenic cells. Cancer Res1989, 49:1941-1947.
20. Beard P, Offord E, Paduwat N, Bruggmann H: SV40 activates transcription from transferrin receptor promoter by inducing a factor which binds to the CRE/AP-1 recognition sequence. Nucleic Acids Res1991, 19:7117-7123.
21. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factors: kappa B activation in intact cells.j Exp Med1992, 175:1181-1194.
22. Franco A, Paroli M, Testa U, Benvenuto R, Peschle C, Balsano F, et al.: Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes, j Exp Med 1992, 175:1195-1205.
23. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S: Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 1982, 27:909-916.
24. Le Sage GD, Baldus WP, Fairbanks VF: Hemochromatosis: genetic or alcohol induced? Gastroenterology 1983, 84:1471-1477.